Advertisement
RayBiotech
RayBiotech

The Scientist

» stock market and immunology

Most Recent

image: Gut Flora Boost Cancer Therapies

Gut Flora Boost Cancer Therapies

By | November 21, 2013

Germ-free or antibiotic-treated mice fare worse than those with rich gut microbiomes during cancer treatment, two studies show.

2 Comments

image: HIV’s Stealth Revealed

HIV’s Stealth Revealed

By | November 21, 2013

HIV-1 evades the immune system with a protein shield, which can be lifted.

2 Comments

image: T cells and Transplantation

T cells and Transplantation

By | November 13, 2013

Drug-resistant immune cells protect patients from graft-versus-host disease after bone marrow transplant.

0 Comments

image: Time for T cells

Time for T cells

By | November 7, 2013

Circadian rhythms control the development of inflammatory T cells, while jet lag sends their production into overdrive.

1 Comment

image: Newborn Immune Systems Suppressed

Newborn Immune Systems Suppressed

By | November 6, 2013

Cells that temporarily restrain their immune systems give babies’ gut bacteria a chance to settle down. 

1 Comment

image: Frisky Fruit Flies

Frisky Fruit Flies

By | November 5, 2013

Researchers show that Drosophila females upregulate an immune gene for protection against sexually transmitted infections before copulation.

1 Comment

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

Researchers find strong correlations between the composition of the human microbiome and genetic variation in immune-related pathways.

4 Comments

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

An immune suppressive drug can unexpectedly help immunized mice fight off many strains of flu.

0 Comments

image: Week in Review: August 26–30

Week in Review: August 26–30

By | August 30, 2013

New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
Advertisement
The Scientist